{"transactions":[{"id":731284,"issuer":{"id":6253,"kind":"organization","name":"PepGen Inc."},"owners":[{"id":36573,"kind":"person","name":"Mayer Howard","position":1,"cik":"0001699610","reported_name":"Mayer Howard","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-22T20:10:46.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next Annual Meeting; provided, however, that all vesting shall cease if the individual ceases to serve as a director, unless the Board of Directors determines that the circumstances warrant continuation of vesting."}],"balance_after":34000,"derivative":{"exercise_price":1.79,"expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001835597-26-000032","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699610/000183559726000032/form4.xml","form_type":"4"}},{"id":1120506,"issuer":{"id":6253,"kind":"organization","name":"PepGen Inc."},"owners":[{"id":36573,"kind":"person","name":"Mayer Howard","position":1,"cik":"0001699610","reported_name":"Mayer Howard","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T10:56:13.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next Annual Meeting; provided, however, that all vesting shall cease if the individual ceases to serve as a director, unless the Board of Directors determines that the circumstances warrant continuation of vesting."}],"balance_after":16000,"derivative":{"exercise_price":1.51,"exercise_date":"2026-06-04","expiration_date":"2035-06-03","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001127602-25-016932","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699610/000112760225016932/form4.xml","form_type":"4"}},{"id":1472604,"issuer":{"id":6253,"kind":"organization","name":"PepGen Inc."},"owners":[{"id":36573,"kind":"person","name":"Mayer Howard","position":1,"cik":"0001699610","reported_name":"Mayer Howard","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-21T20:04:22.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":8667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next Annual Meeting; provided, however, that all vesting shall cease if the individual ceases to serve as a director, unless the Board of Directors determines that the circumstances warrant continuation of vesting."}],"balance_after":8667,"derivative":{"exercise_price":16.8,"exercise_date":"2025-06-20","expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":8667},"source":{"system":"sec-edgar","filing":"0001127602-24-019117","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699610/000112760224019117/form4.xml","form_type":"4"}},{"id":1743043,"issuer":{"id":6253,"kind":"organization","name":"PepGen Inc."},"owners":[{"id":36573,"kind":"person","name":"Mayer Howard","position":1,"cik":"0001699610","reported_name":"Mayer Howard","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-15T00:11:05.000Z","date":"2023-11-10","kind":"grant","planned":false,"acquired":true,"shares":22686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest as follows: One-third (1/3) on November 10, 2024 and the remainder vesting in twenty-four (24) equal monthly installments, subject to the option recipient's continued service or employment with the Company on each applicable vesting date."}],"balance_after":22686,"derivative":{"exercise_price":3.86,"exercise_date":"2024-11-10","expiration_date":"2033-11-09","underlying":"Common Stock","underlying_shares":22686},"source":{"system":"sec-edgar","filing":"0001127602-23-027405","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699610/000112760223027405/form4.xml","form_type":"4"}},{"id":2209500,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":36573,"kind":"person","name":"Mayer Howard","position":1,"cik":"0001699610","reported_name":"Mayer Howard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-07-11T20:06:51.000Z","date":"2022-07-11","kind":"other","acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each Company stock option with a per share exercise price less than the Offer Price, whether or not vested, was terminated and cancelled, and the holder thereof will receive the Offer Price less any applicable per share exercise price for each share subject to such award, pursuant to the terms set forth in the Merger Agreement. Each Company stock option with a per share exercise price equal to or greater than the Offer Price was cancelled immediately prior to the Effective Time, with no consideration payable."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each Company stock option with a per share exercise price less than the Offer Price, whether or not vested, was terminated and cancelled, and the holder thereof will receive the Offer Price less any applicable per share exercise price for each share subject to such award, pursuant to the terms set forth in the Merger Agreement. Each Company stock option with a per share exercise price equal to or greater than the Offer Price was cancelled immediately prior to the Effective Time, with no consideration payable."}],"balance_after":0,"derivative":{"exercise_price":2.98,"underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001104659-22-078796","document":"tm2220760-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1699610/000110465922078796/tm2220760-5_4seq1.xml","form_type":"4"}},{"id":2209499,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":36573,"kind":"person","name":"Mayer Howard","position":1,"cik":"0001699610","reported_name":"Mayer Howard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-07-11T20:06:51.000Z","date":"2022-07-11","kind":"other","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each Company stock option with a per share exercise price less than the Offer Price, whether or not vested, was terminated and cancelled, and the holder thereof will receive the Offer Price less any applicable per share exercise price for each share subject to such award, pursuant to the terms set forth in the Merger Agreement. Each Company stock option with a per share exercise price equal to or greater than the Offer Price was cancelled immediately prior to the Effective Time, with no consideration payable."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each Company stock option with a per share exercise price less than the Offer Price, whether or not vested, was terminated and cancelled, and the holder thereof will receive the Offer Price less any applicable per share exercise price for each share subject to such award, pursuant to the terms set forth in the Merger Agreement. Each Company stock option with a per share exercise price equal to or greater than the Offer Price was cancelled immediately prior to the Effective Time, with no consideration payable."}],"balance_after":0,"derivative":{"exercise_price":2.44,"underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001104659-22-078796","document":"tm2220760-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1699610/000110465922078796/tm2220760-5_4seq1.xml","form_type":"4"}},{"id":2209498,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":36573,"kind":"person","name":"Mayer Howard","position":1,"cik":"0001699610","reported_name":"Mayer Howard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-11T20:06:51.000Z","date":"2022-07-11","kind":"disposition_to_issuer","acquired":false,"shares":27500,"price":2.2,"value":60500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Each Issuer restricted stock unit that was outstanding immediately prior to the date and time at which the merger of Merger Sub with and into the Issuer (the \"Merger\") became effective (the \"Effective Time\") was deemed vested and converted into the right to receive a cash payment equal to the per share Merger consideration of $2.20."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Issuer restricted stock unit that was outstanding immediately prior to the date and time at which the merger of Merger Sub with and into the Issuer (the \"Merger\") became effective (the \"Effective Time\") was deemed vested and converted into the right to receive a cash payment equal to the per share Merger consideration of $2.20."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-22-078796","document":"tm2220760-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1699610/000110465922078796/tm2220760-5_4seq1.xml","form_type":"4"}},{"id":2209497,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":36573,"kind":"person","name":"Mayer Howard","position":1,"cik":"0001699610","reported_name":"Mayer Howard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-11T20:06:51.000Z","date":"2022-07-07","kind":"other","acquired":false,"shares":22000,"price":2.2,"value":48400.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposed of to Innoviva Merger Sub, Inc. (\"Merger Sub\"), which, pursuant to the Agreement and Plan of Merger, dated May 23, 2022, by and between the Issuer, Innoviva, Inc. (\"Innoviva\"), and Merger Sub (the \"Merger Agreement\"), completed a tender offer to acquire all of the issued and outstanding shares of the Issuer's common stock (other than those shares owned by Innoviva and Merger Sub) at a purchase price of $2.20 per share (the \"Offer Price\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of to Innoviva Merger Sub, Inc. (\"Merger Sub\"), which, pursuant to the Agreement and Plan of Merger, dated May 23, 2022, by and between the Issuer, Innoviva, Inc. (\"Innoviva\"), and Merger Sub (the \"Merger Agreement\"), completed a tender offer to acquire all of the issued and outstanding shares of the Issuer's common stock (other than those shares owned by Innoviva and Merger Sub) at a purchase price of $2.20 per share (the \"Offer Price\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-22-078796","document":"tm2220760-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699610/000110465922078796/tm2220760-5_4seq1.xml","form_type":"4"}},{"id":2222480,"issuer":{"id":721,"kind":"organization","name":"Invivyd, Inc.","symbol":"IVVD"},"owners":[{"id":36573,"kind":"person","name":"Mayer Howard","position":1,"cik":"0001699610","reported_name":"Mayer Howard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-24T20:36:24.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 22, 2022 and vests in full on the earlier of (i) June 22, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to continued service through the vesting date."}],"balance_after":75000,"derivative":{"exercise_price":3.09,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000899243-22-024015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699610/000089924322024015/doc4.xml","form_type":"4"}},{"id":2395767,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":36573,"kind":"person","name":"Mayer Howard","position":1,"cik":"0001699610","reported_name":"Mayer Howard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to  Buy)","published_at":"2022-02-15T21:03:11.000Z","date":"2021-07-16","kind":"grant","acquired":true,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Seventy-three (73%) of this award will vest on July 16, 2022, and one-thirteenth of the remaining shares subject to the option will vest monthly following July 16, 2022, subject to the Reporting Person's continuing to provide service through each such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Seventy-three (73%) of this award will vest on July 16, 2022, and one-thirteenth of the remaining shares subject to the option will vest monthly following July 16, 2022, subject to the Reporting Person's continuing to provide service through each such date."}],"balance_after":12500,"derivative":{"exercise_price":2.44,"expiration_date":"2031-07-15","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001104659-22-023776","document":"tm226724-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1699610/000110465922023776/tm226724-6_4seq1.xml","form_type":"4"}},{"id":2395766,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":36573,"kind":"person","name":"Mayer Howard","position":1,"cik":"0001699610","reported_name":"Mayer Howard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-15T21:03:11.000Z","date":"2021-07-16","kind":"disposition_to_issuer","acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 16, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 shares of issuer's common stock granted to the Reporting Person on August 5, 2019. In exchange, the Reporting Person received a replacement option for 12,500 shares of issuer's common stock, having an exercise price of $2.44 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option provided for vesting as follows: The shares subject to this option will vest in equal monthly installments over the three years following the date of grant, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":6.44,"expiration_date":"2029-08-04","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-22-023776","document":"tm226724-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699610/000110465922023776/tm226724-6_4seq1.xml","form_type":"4"}},{"id":2433088,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":36573,"kind":"person","name":"Mayer Howard","position":1,"cik":"0001699610","reported_name":"Mayer Howard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-19T21:03:10.000Z","date":"2022-01-18","kind":"grant","acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award vests in full on the first anniversary of the date of grant, subject to the reporting person's continued service as a director of the Company."}],"balance_after":49500,"source":{"system":"sec-edgar","filing":"0001104659-22-005419","document":"tm223320-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699610/000110465922005419/tm223320-7_4seq1.xml","form_type":"4"}},{"id":2610906,"issuer":{"id":721,"kind":"organization","name":"Invivyd, Inc.","symbol":"IVVD"},"owners":[{"id":36573,"kind":"person","name":"Mayer Howard","position":1,"cik":"0001699610","reported_name":"Mayer Howard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-09T23:59:13.000Z","date":"2021-08-05","kind":"grant","acquired":true,"shares":35593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One third (1/3) of the option shall vest on August 5, 2022, and thereafter, the remainder of the option shall vest in 24 equal monthly installments on the 5th day of each month, subject to the Reporting Person's continuous service on each vesting date."}],"balance_after":35593,"derivative":{"exercise_price":17,"expiration_date":"2031-08-04","underlying":"Common Stock","underlying_shares":35593},"source":{"system":"sec-edgar","filing":"0001209191-21-050492","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699610/000120919121050492/doc4.xml","form_type":"4"}},{"id":2762760,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":36573,"kind":"person","name":"Mayer Howard","position":1,"cik":"0001699610","reported_name":"Mayer Howard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-02T14:36:25.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22000,"source":{"system":"sec-edgar","filing":"0001104659-21-045915","document":"tm2111994-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699610/000110465921045915/tm2111994-4_4seq1.xml","form_type":"4"}},{"id":3012106,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":36573,"kind":"person","name":"Mayer Howard","position":1,"cik":"0001699610","reported_name":"Mayer Howard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-06T20:32:00.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest in equal monthly installments over the 12 months following the date of grant, provided that the option will in any case be fully vested on the date of the  next annual stockholder meeting, subject to the Reporting Persons's continued service through each such vesting date."}],"balance_after":11000,"derivative":{"exercise_price":2.98,"expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001104659-20-112657","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699610/000110465920112657/a4.xml","form_type":"4"}},{"id":3104813,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":36573,"kind":"person","name":"Mayer Howard","position":1,"cik":"0001699610","reported_name":"Mayer Howard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-19T20:13:50.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 100% on the first anniversary of the grant date."}],"balance_after":15000,"derivative":{"exercise_price":2.22,"exercise_date":"2021-06-18","expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001457612-20-000103","document":"wf-form4_159259760895277.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699610/000145761220000103/wf-form4_159259760895277.xml","form_type":"4"}},{"id":3446204,"issuer":{"id":16036,"kind":"organization","name":"Entasis Therapeutics Holdings Inc.","symbol":"ETTX"},"owners":[{"id":36573,"kind":"person","name":"Mayer Howard","position":1,"cik":"0001699610","reported_name":"Mayer Howard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-06T20:10:42.000Z","date":"2019-08-05","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest in equal monthly installments over the three years following the date of grant, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":6.44,"expiration_date":"2029-08-04","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-19-044300","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699610/000110465919044300/a4.xml","form_type":"4"}},{"id":3458811,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":36573,"kind":"person","name":"Mayer Howard","position":1,"cik":"0001699610","reported_name":"Mayer Howard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-19T20:11:11.000Z","date":"2019-07-18","kind":"grant","acquired":true,"shares":5625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 100% on the first anniversary of the grant date."}],"balance_after":5625,"derivative":{"exercise_price":3.66,"exercise_date":"2020-07-18","expiration_date":"2029-07-18","underlying":"Common Stock","underlying_shares":5625},"source":{"system":"sec-edgar","filing":"0001457612-19-000114","document":"wf-form4_156356705552014.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699610/000145761219000114/wf-form4_156356705552014.xml","form_type":"4"}},{"id":3884488,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":36573,"kind":"person","name":"Mayer Howard","position":1,"cik":"0001699610","reported_name":"Mayer Howard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-26T00:08:27.000Z","date":"2018-06-21","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 100% on the first anniversary of the grant date."}],"balance_after":45000,"derivative":{"exercise_price":0.99,"exercise_date":"2019-06-21","expiration_date":"2028-06-21","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001457612-18-000070","document":"wf-form4_152997169151474.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699610/000145761218000070/wf-form4_152997169151474.xml","form_type":"4"}},{"id":4399244,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":36573,"kind":"person","name":"Mayer Howard","position":1,"cik":"0001699610","reported_name":"Mayer Howard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-07T21:01:51.000Z","date":"2017-03-06","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests annually in equal installments over a three-year period beginning on the date of grant."}],"balance_after":25000,"derivative":{"exercise_price":4.98,"expiration_date":"2027-03-06","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001699610-17-000004","document":"wf-form4_148892049729106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699610/000169961017000004/wf-form4_148892049729106.xml","form_type":"4"}}]}